(ALX) Alexanders - Ratings and Ratios
Office, Retail, Apartments, Mixed-Use, Real Estate
ALX EPS (Earnings per Share)
ALX Revenue
Description: ALX Alexanders
Alexanders, Inc. is a real estate investment trust (REIT) that specializes in leasing, managing, and redeveloping properties in the New York City metropolitan area. The company operates through its manager, Vornado Realty Trust, and has a portfolio of five key properties, including the prestigious 731 Lexington Avenue office and retail complex, which serves as the world headquarters for Bloomberg, L.P.
The companys properties are strategically located in high-demand areas, with 731 Lexington Avenue being a prime example of a high-quality asset that generates significant rental income. Additionally, Alexanders has a presence in Queens with the Rego Center complex, which includes retail properties and a luxury apartment tower, The Alexander. The companys retail property in Flushing, NY, further diversifies its portfolio.
From a financial perspective, Alexanders has demonstrated a strong track record of performance, with a return on equity (RoE) of 21.34%. The companys market capitalization stands at $1.17 billion, with a price-to-earnings (P/E) ratio of 29.69. While the forward P/E ratio is not available, the current valuation suggests that investors are willing to pay a premium for the companys shares, likely due to its stable cash flows and growth prospects.
Analyzing the technical data, Alexanders stock price is currently trading at $226.46, with a 20-day simple moving average (SMA) of $224.62 and a 50-day SMA of $211.81. The stock is also above its 200-day SMA of $207.62, indicating a longer-term uptrend. The average true range (ATR) is $5.26, representing a 2.32% daily price movement. Given the current technical and fundamental data, a forecast for Alexanders stock price could be moderately bullish, with potential for the stock to reach $240 in the near term, driven by its strong fundamentals and favorable technical indicators.
Based on the analysis, it is likely that Alexanders will continue to benefit from its high-quality properties and strong management, driving long-term value creation for shareholders. As the company continues to optimize its portfolio and capitalize on growth opportunities, investors may want to consider accumulating shares of ALX, with a target price of $240.
ALX Stock Overview
| Market Cap in USD | 1,138m |
| Sector | Real Estate |
| Industry | REIT - Retail |
| GiC Sub-Industry | Retail REITs |
| IPO / Inception | 1984-07-19 |
ALX Stock Ratings
| Growth Rating | 20.6 |
| Fundamental | 52.7% |
| Dividend Rating | 48.6 |
| Rel. Strength | 8.33 |
| Analysts | 2.00 of 5 |
| Fair Price Momentum | 213.27 USD |
| Fair Price DCF | 185.79 USD |
ALX Dividends
| Dividend Yield 12m | 8.48% |
| Yield on Cost 5y | 10.26% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 32.6% |
| Payout Ratio | 2.5% |
ALX Growth Ratios
| Growth Correlation 3m | 68.1% |
| Growth Correlation 12m | 25.6% |
| Growth Correlation 5y | 24.3% |
| CAGR 5y | 4.24% |
| CAGR/Max DD 5y | 0.11 |
| Sharpe Ratio 12m | 0.30 |
| Alpha | -4.62 |
| Beta | 0.577 |
| Volatility | 23.88% |
| Current Volume | 56k |
| Average Volume 20d | 44.9k |
| Stop Loss | 209.1 (-3.1%) |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (37.4m TTM) > 0 and > 6% of Revenue (6% = 13.1m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 12.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 169.8% (prev 253.7%; Δ -83.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 85.1m > Net Income 37.4m (YES >=105%, WARN >=100%) |
| Net Debt (-313.0m) to EBITDA (92.8m) ratio: -3.37 <= 3.0 (WARN <= 3.5) |
| Current Ratio 8.05 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (5.13m) change vs 12m ago 0.05% (target <= -2.0% for YES) |
| Gross Margin 58.58% (prev 52.08%; Δ 6.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 22.91% (prev 15.74%; Δ 7.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.40 (EBITDA TTM 92.8m / Interest Expense TTM 54.0m) >= 6 (WARN >= 3) |
Altman Z'' 7.19
| (A) 0.88 = (Total Current Assets 422.8m - Total Current Liabilities 52.5m) / Total Assets 422.8m |
| (B) 0.25 = Retained Earnings (Balance) 105.6m / Total Assets 422.8m |
| (C) 0.08 = EBIT TTM 75.5m / Avg Total Assets 951.8m |
| (D) 0.09 = Book Value of Equity 110.8m / Total Liabilities 1.18b |
| Total Rating: 7.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.74
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 3.94% = 1.97 |
| 3. FCF Margin 32.73% = 7.50 |
| 4. Debt/Equity 6.79 = -2.50 |
| 5. Debt/Ebitda 10.64 = -2.50 |
| 6. ROIC - WACC data missing |
| 7. RoE 22.12% = 1.84 |
| 8. Rev. Trend 6.19% = 0.31 |
| 9. Rev. CAGR -1.35% = -0.22 |
| 10. EPS Trend -46.43% = -1.16 |
| 11. EPS CAGR -26.05% = -2.50 |
As of August 12, 2025, the stock is trading at USD 215.88 with a total of 56,001 shares traded.
Over the past week, the price has changed by +1.16%, over one month by -5.97%, over three months by +1.58% and over the past year by +10.49%.
Neither. Based on ValueRay´s Fundamental Analyses, Alexanders is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 52.74 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALX is around 213.27 USD . This means that ALX is currently overvalued and has a potential downside of -1.21%.
Alexanders has received a consensus analysts rating of 2.00. Therefor, it is recommend to sell ALX.
- Strong Buy: 0
- Buy: 0
- Hold: 0
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, ALX Alexanders will be worth about 236.8 in August 2026. The stock is currently trading at 215.88. This means that the stock has a potential upside of +9.7%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 155 | -28.2% |
| Analysts Target Price | 165 | -23.6% |
| ValueRay Target Price | 236.8 | 9.7% |
ALX Fundamental Data Overview
CCE Cash And Equivalents = 313.0m USD (last quarter)
P/E Trailing = 30.561
P/S = 5.2174
P/B = 7.8231
Beta = 0.813
Revenue TTM = 218.1m USD
EBIT TTM = 75.5m USD
EBITDA TTM = 92.8m USD
Long Term Debt = 987.6m USD (from longTermDebt, last quarter)
[93m Short Term Debt = unknown (0.0)
[39m Debt = 987.6m USD (Calculated: Short Term 0.0 + Long Term 987.6m)
Net Debt = -313.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.81b USD (1.14b + Debt 987.6m - CCE 313.0m)
Interest Coverage Ratio = 1.40 (Ebit TTM 75.5m / Interest Expense TTM 54.0m)
FCF Yield = 3.94% (FCF TTM 71.4m / Enterprise Value 1.81b)
FCF Margin = 32.73% (FCF TTM 71.4m / Revenue TTM 218.1m)
Net Margin = 17.14% (Net Income TTM 37.4m / Revenue TTM 218.1m)
Gross Margin = 58.58% ((Revenue TTM 218.1m - Cost of Revenue TTM 90.3m) / Revenue TTM)
Tobins Q-Ratio = 16.36 (Enterprise Value 1.81b / Book Value Of Equity 110.8m)
Interest Expense / Debt = 1.30% (Interest Expense 12.8m / Debt 987.6m)
[93m Taxrate = 100.0% (set to none) (from yearly Income Tax Expense: 43.4m / 43.4m)
[39m[93m NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
[39m Current Ratio = 8.05 (Total Current Assets 422.8m / Total Current Liabilities 52.5m)
Debt / Equity = 6.79 (Debt 987.6m / last Quarter total Stockholder Equity 145.4m)
Debt / EBITDA = 10.64 (Net Debt -313.0m / EBITDA 92.8m)
Debt / FCF = 13.84 (Debt 987.6m / FCF TTM 71.4m)
Total Stockholder Equity = 169.0m (last 4 quarters mean)
RoA = 8.84% (Net Income 37.4m, Total Assets 422.8m )
RoE = 22.12% (Net Income TTM 37.4m / Total Stockholder Equity 169.0m)
RoCE = 6.53% (Ebit 75.5m / (Equity 169.0m + L.T.Debt 987.6m))
[93m RoIC = unknown (NOPAT none, Invested Capital 1.16b, Ebit 75.5m)
[39m[93m WACC = unknown (E(1.14b)/V(2.13b) * Re(8.14%)) + (D(987.6m)/V(2.13b) * Rd(1.30%) * (1-Tc(none)))
[39m Shares Correlation 5-Years: 100.0 | Cagr: 0.04%
Discount Rate = 8.14% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 75.80% ; FCFE base≈71.4m ; Y1≈63.9m ; Y5≈54.2m
Fair Price DCF = 185.8 (DCF Value 948.9m / Shares Outstanding 5.11m; 5y FCF grow -13.00% → 2.90% )
Revenue Correlation: 6.19 | Revenue CAGR: -1.35%
Revenue Growth Correlation: -72.38%
EPS Correlation: -46.43 | EPS CAGR: -26.05%
EPS Growth Correlation: -27.93%
Additional Sources for ALX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle